TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma

Aim: Hepatocellular carcinoma (HCC) is considered to be the third leading cause of cancer death. The homologous gene of TP53 is significant in the occurrence and development of cancer. This study explored the relationship between TP53 rs28934571 polymorphism and HCC risk in Guangxi, China. Materials & methods: We first screened the association through bioinformatics. Additionally, a case-control study was performed to further verify the relationship between gene polymorphism and HCC risk after collecting clinical characteristics. Results: Results showed that allele A on TP53 rs28934571 was a risk factor for HCC and mutation from C to A on TP53 rs28934571 would increase the risk of poor prognosis of HCC. Conclusion: Therefore, the study concluded that TP53 rs28934571 may become a diagnostic indicator in judging the prognosis of HCC.

Automated summary

This study investigated the relationship between TP53 rs28934571 polymorphism and HCC risk in Guangxi, China, suggesting that allele A on TP53 rs28934571 may be a risk factor for HCC and mutation from C to A could increase the risk of poor prognosis of HCC. It concluded that TP53 rs28934571 may serve as a diagnostic indicator for judging the prognosis of HCC.